15
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Multiple Chemical Sensitivity: Recognition and Management. A document on the health effects of everyday chemical exposures and their implications

, , , , , , , , & show all
Pages 39-84 | Published online: 13 Jul 2009

References

  • BSAEM/BSNM Subcommittee. Effective Allergy Practice: A Document on Standards of Care and Managemen t for the Allergy Patient, British Society for Allergy Environmental and Nutritional Medicine. 1994.
  • BSAEM/BSNM Subcommittee. Effective Nutritional Medicine: the applicatio n of nutrition to major health problems, British Society for Allergy Environmenta l and Nutritiona l Medicine. 1995.
  • Randolph T. Human Ecology and Susceptibilit y to the Chemical Environment. Springfield, IL: Charles C Thomas, 1962 (previousl y publishe d in eight parts in Ann Allergy 1961; 19: 518–40, 657–77, 779–99 and 908–26).
  • Miller CS. White paper: Chemical sensitivity: history and phenomenology. Toxicol Indust Health 1994; 10: 253–76.
  • Ziem G, McTamney J. Profile of patients with chemical injury and sensitivity. Environ Health Perspect 1997; 105 (Suppl 2): 417–36.
  • Ross GH. Clinical characteristic s of chemical sensitivity: an illustrativ e case history of asthma and MCS. Environ Health Perspect 1997; 105 (Suppl 2): 437–41.
  • Ashford NA, Miller CS. Chemical Exposures Low Levels and High Stakes. New York: Van Nostrand Reinhold, 1998 (2nd edn.).
  • Graveling RA, Pilkington A, George JPK, et al. A review of multiple chemical sensitivity. Occup Environ Med 1999; 56: 73–85.
  • Anthony H, Birtwistle S, Eaton K, Maberly J. Environmental Medicine in Clinical Practice. BSAENM Publications, Southampton, 1997. (ISBN 0 9523397 2 2).
  • Pepys J. Chemical dusts, vapour s and fumes causing asthma. Environment Internationa l 1982; 8:321– 5.
  • Kilburn KH. Editorial. Measuring the effects of chemicals on the brain. Arch Environ Health 1999; 54: 150.
  • AU WW, Cantelli-Fort i G, Hrelia P, et al. Cyogenic assays in genotoxi c studies: somatic cell effects of benzene and germinal cell effects of dibromochloropropane. Teratog Carcinog Mutagen 1990; 10: 125–34.
  • Lax MB, Henneberge r PK. Patients with multiple chemical sensitivitie s in an occupationa l health clinic: presentatio n & follow-up. Arch Environ Health 1995; 50: 425–31.
  • Davidoff AL, Keyl PM, Meggs W. Developmen t of multiple chemical sensitivitie s in laborer s after acute gasolin e fume exposur e in an undergroun d tunnelin g operation. Arch Environ Health 1998; 53: 183–9.
  • European Environment Agency. Chemicals in the Environment: Low Doses, High Stakes? EEA & UNEP, 1998.
  • Anonymous. Poisoning our children: The dangers of exposur e to unteste d and toxic chemicals. London: Friends of the Earth, 1998.
  • Mitchell FL (ed.) Multiple Chemical Sensitivity: A Scientific Overview. US Dept Health and Human Sciences/US Public Health Service/US Agency for Toxic Substance s and Disease Registry, Part 1 Proceeding s of a Workshop in March 1991 for the Environmental Protection Agency. Princeton, NJ: Princeton Scientific Publishing, 1995.
  • Rest KM (ed.) Proceedings of the Associatio n of Occupationa l and Environmental Clinics (AOEC) Workshop on Multiple Chemical Sensitivity. Toxicol Ind Health 1992; 8: 1–257 (republishe d in [17], Part II).
  • Mitchell FL (ed.) Proceeding s of the Conferenc e on Low-level Exposure to Chemicals and Neuro-biologi c Sensitivity, sponsored by the US Agency for Toxic Substance s and Disease Registry. Toxicol Ind Health 1994; 10: 253–666 (republishe d in [17], Part III).
  • Kreutzer R, Neutra R. Evaluatin g individual s reportin g sensitivitie s to multiple chemicals. Agency for Toxic Substances and Disease Registry. (publicatio n #PB96–187646) June 1996.
  • Fielder N, Kipen H. Experimental Approaches to Chemical Sensitivity. Monograp h based on papers presente d at a workshop in September 1995 sponsore d by the US National Institut e of Environmenta l Health Sciences and the US Environmenta l and Occupationa l Health Sciences Institute. Environmenta l Health Perspectives 1997; 105 (Suppl 2): 405–547.
  • Green M. Introduction. In: How Vehicle Pollution Affects our Health. Read C (ed.), The Ashden Trust, 1994: 2–7.
  • Chemical Industrie s Association. Chemicals in the Environment, 1998. Response to the DETR consultatio n paper on ‘Sustainabl e Production and Use of Chemicals’.
  • Rea WJ. Chemical Sensitivity: Vol. 2. Sources of Total Body Load. Lewis: Boca Raton, 1994.
  • Mage D, Gammage R. Evaluation of change s in outdoor air quality occurrin g over the past several decades. In: Gammage R, Kaye S (eds.) Indoor air and Human Health. Lewis: Chelsea, MI, 1985: 10.
  • UK Plastics Industry. Performance Summary, 1992. British Plastics Federation, London 1992.
  • Miller M. Danger! Additives at Work. London Food Commission: London, 1985.
  • ACARD. The Food Industr y and Technology. Advisory Council for Applied Research and Develop- ment. HMSO: London, 1982.
  • Hopp V, Henning I. Handbook of Applied Chemistry: Facts for Engineers, Scientists, Technicians and Technical Managers. Hemisphere Publishing: Washington DC, 1983, vol II, 4–16.
  • Ward N, Clark J, Lowe P, et al. Water Pollution from Agricultural Pesticides. Research Report, University of Newcastle upon Tyne, 1993.
  • Beaumont P. Pesticides, Policies and People. The Pesticides Trust: London, 1993.
  • Taylor D, Maynar d A. Medicines, the NHS and Europe. Balancing the public’s interests. King’s Fund Institute Briefing Paper No. 11, London, 1990.
  • Silicone Gel Breast Implants: The Report of the Independen t Review Group July 1998 (ISBN 1 85839 909 2).
  • Baird DN, Rea WJ. The Temporomandibula r Joint Implant Controversy: A Review of Autogenous/Alloplasti c Materials and Their Complications”. J Nutr Environ Med 1998; 8: 289–300.
  • Brauweiler PH, Wehler T, Busin M High incidence of cataract formation after implantatio n of a silicone posterio r chamber lens in phakic, highly myopic eyes. Ophthalmology 1999; 106: 1651–5.
  • British National Formulary No 37, March, 1999
  • EEA/UNEP Chemicals in the Environment: low doses, high stakes? Annual Message 2 on the State of the European Environment. EEA 1998.
  • Hasoff BH. Synergisti c toxicity of food additive s in rats fed a diet low in dietary fiber. J Food Sci 1976; 41; 947–51.
  • Abou-Doma MB, Wilmarth KR. Neurotoxicit y resultin g from co-exposur e to pyridostigmin e bromide, DEET and permethrin: implication s of Gulf War chemical exposures. J Toxicol Env Health 1996; 48: 35–56.
  • Brooks SM, Gochfield M, Hertzstein J, et al (eds.) Environmental Medicine. St Louis: Mosby, 1995.
  • Bates DV. Air pollution: time for more clean air legislation ? BMJ 1996; 312: 649–50.
  • Schwartz J, Marcus A. Mortality and air pollutio n in London: a time series analysis. Am J Epidemiol 1990; 131: 185–94.
  • Xu X, Ding H, Wang X. Acute effects of suspended particles and sulfur dioxide s on preterm delivery: a community-base d cohort study. Arch Environ Health 1995; 50: 407–15.
  • MacPhail RC. Evolving Concepts of Chemical Sensitivity. Environmenta l Health Perspectives 1997; 105 (Suppl. 2): 455–56.
  • Calabrese EJ. Pollutants and High-Risk Groups: the biologica l basis of increased human susceptibilit y to environmenta l and occupationa l pollutants. New York: John Wiley & Sons, 1978.
  • Crawford MA, Hassam AG, Williams G. Essential fatty acids and fetal brain growth. Lancet 1976; i: 452–3.
  • Keen CL, Bendich A, Willhite CC (eds.) Maternal Nutrition and Pregnanc y Outcome. Ann NY Acad Sci 1993; 678: 1–370.
  • Salama AK, Bakry NM, Abou-Donia MB. A review article on placenta l transfe r of pesticides. Int J Occup Med Toxicol 1993; 2: 383–97.
  • Nakagawa R, Hirakawa H, Iida T, et al. Maternal body burden of organochlorin e pesticide s and dioxins. J AOAC Int 1999; 82: 716–24.
  • Barker DJP. Fetal origins of coronar y heart disease. BMJ 1995; 311: 171–4.
  • Block G, Abrams B. Vitamin and mineral status of women of childbearin g potential. Ann NY Acad Sci 1993; 678: 244–54.
  • Benton D, Haller J, Fordy J. The vitamin status of young British adults. Interna t J Vit Res 1997; 67: 34–40.
  • Scholl TO, Hedigar ML, Bendich A, et al. Use of multivitamin /mineral prenatal supplements: influence on the outcome of pregnancy. Am J Epidemiol 1997; 146: 134–41.
  • Barclay MN, MacPherson A. Selenium content of wheat flour used for bread making in Scotland and the relationshi p between glutathion e peroxidas e levels in whole blood and bread consumption. Br J Nutr 1992; 68: 261–70.
  • Maberly DJ, Anthony HM. Serum zinc in a series of allergy patients. J Nutr Environ Med 1997; 7: 62–3.
  • Jackson AJ, Schumacher HJ. The teratogeni c activity of thalidomid e analogu e EM12 in rats fed a low zinc diet. Teratology 1979; 19: 341–4.
  • Fratta ID, Sigg EB, Maiorana K. Teratogeni c effect of thalidomide in rabbits, rats, hamster s and mice. Toxicol Appl Pharmacol 1965; 7: 268–86.
  • Dolk M, Vrijherd M, Armstrong B, et al. Risk of congenita l abnormalitie s near hazardous-wast e landfill sites in Europe: the EUROHAZCON Study. Lancet 1998; 352: 423–27.
  • Downing D. Health Consequence s of the Pre-Aral Disaster. J Nutr Environ Med 1995; 5: 391–9.
  • Price WA. Nutrition and Physical Degeneration. Price-Pottenge r Nutrition Foundatio n Inc.: La Mesa, California, 1943 (reprinte d 1979).
  • Davies S. Editorial. Scientif c and Ethical Foundations of Nutritiona l and Environmenta l Medicine. Part III: Pharmacology—The Teaching of Pharmacotherapeutic s as a First Line of treatment in Clinical Medical Practice; A: Consideratio n of Hippocrati c and Darwinian-Evolutionar y Principles. J Nutr Environ Med 1997, 7: 219–32.
  • Walker G. Associatio n of the British Pharmaceutica l Industry Compendium of Data Sheets and Summaries of Product Characteristics. Datapharm: London, 1998.
  • Porter J, Jick H. Drug-relate d deaths among inpatients. JAMA 1977; 237: 879–81.
  • Willianeso n J, Chopin JM. Adverse reaction to prescribed drugs in the elderly. A multi-centr e investigation. Age Ageing 1980; 9: 73–80.
  • Caucino JA, Armenaka M, Rosenstreic h DL. Anaphylaxi s associate d with a change in premarin dye formulation. Ann Allergy 1994; 72(1): 33–5.
  • Gregory GF. Silicone-associate d tissue reaction: a dilemma for oral and maxillofacia l surgeons. Br J Oral Maxillofa c Surg 1995; 33(3): 180–4.
  • Shanklin DR, Smalley DL. The Immunopatholog y of Siliconosis. Immunologi c Research 1998; 18: 125–73.
  • Lori Brown S, Silverman BG, Berg WA. Rupture of silicone-ge l breast implants: causes, sequelae and diagnosis. Lancet 1997; 350: 1531–7.
  • Met-Chem testing lab report 15.9.95.
  • Henry Jenny. Silicone-Gate, 1994.
  • James PB, Hills BA. Letter. BMJ, 17 April 1996.
  • Medical Devices Agency. Evaluation report, February 1993.
  • Shanklin DR, personal communication.
  • Pfleiderer B, et al. Patients with Silicone Implants: Defect Diagnosis, Exposur e to Silicone and Symptomatology. Vortag auf dem Meeting Sept 1997: European Society of Magnetic Resonanc e in Medicine and Biology, Brussels.
  • Ericsson AD. Syndromes associate d with breast implants. J Nutr Environ Med 1998; 8: 35–52.
  • Lappe MA. Silicone-reactiv e disorder: a new autoimmune disease caused by immunostimulatio n and superantigens. Med Hypotheses 1993; 41(4): 348–52.
  • Vos JG. National Institute of Public Health and the Environment, The Netherland s 15.12.98.
  • Barr RD, Rees PH, Cordy PE, et al. Nephrotic syndrome in adult Africans in Nairobi. BMJ 197; 2: 131–4.
  • Friberg L. Environmental Health Criteria for Inorgani c Mercury. In: Friberg L (ed.) Environmenta l Health Criteria, Document 118. Geneva: World Health Organisatio n 1991; 21.
  • Hahn LJ, Kloiber R, Leininger RW, et al. Whole body imaging of the distributio n of mercury released from dental fillings into monkey tissues. FASEB 1990; 4: 3256–60.
  • Vimy M, Takahash i Y, Lorscheide r F. Maternal-feta l distributio n of mercur y release d from dental fillings into monkey tissues. Am J Physiol 1990; 258: 939–45.
  • Lorscheide r FL, Vimy MJ. Mercury exposur e from ‘silver’ fillings. Lancet 1991; 337: 1103.
  • Vimy M, Lorscheider F. Dental amalgam mercury daily dose estimated from intra-ora l vapour measurements: a predicto r of mercury accumulatio n in human tissues. J Trace Elem Exp Med 1990; 3: 111–23.
  • McLaren-Howard J. Quoted in Anthony et al. Environmental Medicine in Clinical Practice. BSAENM Publications, Southampton, 1997, p. 206.
  • Vimy M, Lorscheider F. Intra-ora l air mercury released from dental amalgam. J Dental Research 1985; 64(B): 1069–71.
  • Kuhnert P, Kuhnert BR, Erkard P. Comparison of mercury levels in maternal blood, foetal cord blood and placenta l tissues. Am J Obstet Gynaecol 1981; 139: 209–12.
  • Sood PP, Vijayalakshm i K. Vitamin status in mice tissues during methyl mercury intoxicatio n and detoxication. J Nutr Environ Med 1995; 5: 133–41.
  • Thompson C, Markesbur y W, Ehmann W, et al. Regional trace-elemen t studies in Alzheimer’s disease. Neurotoxicolog y 1988; 9: 1–8.
  • Nylander M. Mercury in the pituitar y glands of dentists. Lancet 1986; 1: 442.
  • Shapiro IM, Cornblath DR, Summer AJ, et al. Neurophysiologica l and neuropsychologica l functio n in mercury-expose d dentists. Lancet 1982; 1: 1147–50.
  • Rowland A, Baird D, Weinberg C, et al. The effect of occupationa l exposur e to mercury vapour on the fertility of female dental assistants. Occup Environ Med 1994; 51: 28–34.
  • Malamum D, Dietrich SA, Shapiro IM. Low levels of mercury inhibit the respirator y burst in human polymorphonuclea r leukocytes. Biochem Biophys Res Comm 1985; 128(3): 1145–51.
  • Shenker BJ, Berthold P, Rooney C, et al. Immunotoxi c effects of mercuric compound s on human lymphocytes and monocytes. iii Alteration s in B-cell function and viability. Immunopharmaco l Immunotoxico l 1993; 15(1): 87–112.
  • Djerassi E, Berova N. The possibilitie s of allergic reaction s from silver amalgam restorations. Internat Dental J 1969; 19: 481–8.
  • Lichtenber g H. Elimination of symptoms by removal of dental amalgam from mercury poisoned patients as compared with a control group of average patients. J Orthomolecula r Med 1993; 8: 145–8.
  • Colborn T, Peterson Myers J, Dumanoski D. Our Stolen Future. Little Brown: London, 1996.
  • BSAEM/BSNM. Evidence of adverse effects of pesticides. J Nutr Environ Med 1995; 5: 341–52.
  • Franklin AJ. Tap-water contaminant s and illnesses caused thereby. In: The Recognitio n and Managemen t of Food Allergy in Children. Franklin AJ (ed.) Parthenon Publishing: Carnforth, 1988: 133–8.
  • Walker CH. Wild birds as indicator s of pesticid e use and agricultura l practice. In: Biological Indicator s of Pollution. Richardso n DHS (ed.) Royal Irish Academy, Dublin, 1987: 169–81.
  • Fletcher MR, Hunter K, Quick MP, et al. Pesticide Poisoning in Animals 1990. Investigation s of Suspected Incident s in Great Britain. A Report of the Environmenta l Committee on Pesticides. MAFF: London, 1991.
  • Mineau P. Cholinesterase-inhibitin g Insecticides: Impact on Wildlife and the Environment. Elsevier: Amsterdam, 1991.
  • Fein G, Jacobsen J, et al. Prenatal exposur e to PCBs: effects on birth size and gestationa l age. J Pediatr 1984; 105: 315–20.
  • Jacobsen J, Fein G, et al. Effects of in utero exposur e to PCBs and related contaminant s on cognitiv e functionin g in young children. J Pediatr 1990; 116: 38–45.
  • Hoyer AP, Grandjean P, Jorgeso n T, Brock JW, Hartvig HB. Organochlorin e exposur e and risk of breast cancer. Lancet 1998; 352: 1816–20.
  • Butterfield PG, Vahanis BG, Spencer PS, et al. Environmental antecedent s of young-onse t Parkinson ’s disease. J Am Acad Neurol 1993; 43: 1150–8.
  • Barbeau A, Ray M, Bernier G, et al. Ecogenetic s of Parkinson ’s disease: prevalenc e and environmen - tal aspects in rural areas. Can J Neurol Sci 1987; 14: 36–41.
  • Fleming L, Mann JB, Bean J, et al. Parkinson ’s disease and brain levels of organochlorin e pesticides. Ann Neurol 1994; 36: 100–3.
  • Smith EM, Hammons-Ehlers M, Clark MK, et al. Occupationa l exposures and the risk of female infertility. J Occup Environ Med 1997; 39: 138–47.
  • Savitz DA, Arbuckle T Kaczor D, et al. Male pesticide exposur e and pregnanc y outcome. Am J Epidemiol 1997; 146: 1025–36.
  • Newsome WH, Ryan JJ. Toxaphen e and other chlorinate d compounds in human milk from northern and souther n Canada: a comparison. Chemospher e 1999; 39: 519–26.
  • Sigmund E. An examination of Government advice to sheep dipper s on the true hazards of using OP dips, and the sources of recommendation s on protectiv e equipment. OP Information Network: Callington, 1998.
  • Stephens R, Spurgeon A, Calvert IA. Neuropsychologica l effects of long term exposur e to organophosphate s in sheep dip. Lancet 1995; 345: 1135–9.
  • Davies DR. Organophosphates, affectiv e disorder s and suicide. J Nutr Environ Med 1995; 5: 367–74.
  • Forbat IN, Skehan JD. Letter. BMJ 1992; 305: 1503.
  • Royal College of Physicians/Royal College of Psychiatrists. Organophosphat e Sheep Dip; Clinical Aspects Of Long Term Low-Dose Exposure, 1998.
  • Leiss JK, Savitz DA. Home pesticid e use and childhoo d cancer: a case-contro l study. Am J Pub Health 1995; 85: 249–52.
  • Anonymous. Chronic neurologica l effects of organophosphat e pesticides. Editorial. BMJ 1996; 312: 1312.
  • Anonymous. Organophosphoru s compounds: good, bad and difficult. Editorial. Lancet 1998; 352: 499.
  • Calabrese EJ. Nutritional and Environmental Health: the Influence of Nutritiona l Status on Pollutant Toxicity and Carcinogenicity, vol I, The Vitamins. John Wiley: New York, 1980.
  • Calabrese EJ. Nutritional and Environmental Health: the Influence of Nutritiona l Status on Pollutant Toxicity and Carcinogenicity, vol II, Minerals and Macronutrients. John Wiley: New York, 1981.
  • Compston JE, Vedi S, Stephen AB, et al. Reduced bone formation after exposur e to organophosphates. Lancet 1999; 354: 1791–2.
  • Fukeda K, Nisenbau m R Stewart G, et al. Chronic multisyste m illness affecting air force veteran s of the gulf war. JAMA 1998; 28:981 –8.
  • The Iowa Persian Gulf study group. Self-reporte d illness and health status among Persian Gulf War veterans: a population-base d study. JAMA 1997; 277: 238–45.
  • Haley R. Point: bias from the ‘healthy warrior effect’ and unequal follow up in three governmen t studies of health effects of the Gulf War. Am J Epidemiol 1998; 148: 315–23.
  • Unwin C, Blatchley N, Coker W, et al. Health of U.K. serviceme n who served in the Persian Gulf War. Lancet 1999; 353: 169–78.
  • Ismail K, Everitt B, Blatchley N, et al. Is there a Gulf War syndrome ? Lancet 1999; 353: 179–82.
  • Coker WJ, Bhatt BM, Blatchley NF, et al. Clinical findings for the first 1000 Gulf war veteran s in the Ministr y of Defence’s medical asessment programme. BMJ 1999; 318: 290–4.
  • Miller C. Chemical Sensitivity: Symptom, Syndrome or Mechanism for Disease? Toxicolog y 1996; 11: 69–86.
  • Simon TR, Hickey DC, Fincher CE, et al. Single photon emission computed tomograph y of the brain in patients with chemical sensitivities. Toxicol Ind Health 1994; 10: 573–7.
  • Bell IR, Warg-Damiani L, Baldwin CM, et al. Self-reported chemical sensitivit y and wartime chemical exposure s in Gulf War Veterans with and without decreased global health ratings. Mil Med 1998; 163: 725–32.
  • Bartha L, et al. Multiple Chemical Sensitivity: a 1999 consensus. Arch Environ Health 1999; 54: 147–9.
  • Hirzy J, Morison R. Unpublished. See ref. [7]. p. 70.
  • Fox RA, Shires DB, Fox HM, et al. Environmentally-induce d dysfunction: the Camp Hill medical experience. J Nutr Environ Med 1996; 6: 351–8.
  • Robb N. The environmen t was right for Nova Scotia’s new environmenta l health clinic. Canad Med Assoc J 1995; 152: 1292–4.
  • Eaton KK. Medical Aspects. In: Rostron J (ed.) Sick Building Syndrome. Concepts, Issues and Practice. Spon: London, 1997: 57–67.
  • Bardana EJ, Montanaro, O’Hollaren MT. Building-relate d illness: review of the scientific data. Clin Rev Allergy 1988; 6: 61–89.
  • Baldry C, Bain P, Taylor P. Human resource management. In: Rostron J (ed.) Sick Building Syndrome. Concepts, Issues and Practice. Spon: London, 1997: 99–123.
  • Eaton KK, Owen BJ. Building related sickness: remedies for recovery. Building Services: the CIBSE Journal 1993; 15 (3): 26.
  • Binder RE, Mitchell CA, Hosein HR, et al. Importanc e of the indoor environmen t in air pollution exposure. Arch Environ Health 1976; 31: 277–9.
  • Helsing KJ, Comstock GW, Meyer MB, et al. Respirator y effects of househol d exposures to tobacco smoke and gas cooking on non-smokers. Environ Int 1982; 8: 365–70.
  • Molhave L. Indoor air pollutio n due to organic gases and vapour s of solvent s in building materials. Environ Int 1982; 8: 117–27.
  • Anthony H, Birtwistle S, Eaton K, Maberly J. Environmental Medicine in Clinical Practice. BSAENM Publications, Southampton, 1997, p. 353.
  • Coggan D. Air pollutio n in homes. BMJ 1996; 312: 1316.
  • Farrow A, Taylor H, Golding J. Symptoms of mothers and infants, level of measured volatile organic compound s and use of aerosol s and air fresheners. Proceedings of the Indoor Air Conference, Edinburgh, 1999; 2: 286–91.
  • Bell I, Miller C, Schwartz G, et al. Neuropsychiatri c and somatic characteristic s of young adults with and without self-reporte d chemical odor intoleranc e and chemical sensitivity. Arch Environ Health 1996; 51: 9–21.
  • Meggs W, Dunn K, Bloch R, et al. Prevalenc e and nature of allergy and chemical sensitivit y in a general population. Arch Environ Health 1996; 51: 275–82.
  • Kruetzer R, Neutra R., et al. Prevalence of people reportin g sensitivitie s to chemicals in a population –based survey. Am J Epidemiol 1999; 150: 1–12; comments 13–17.
  • Environmenta l Protection Agency 1989. Quoted by Ashford NA, Miller CS (eds) Chemical Exposures Low levels and High Stakes. New York: Van Nostrand Reinhold, 1998 (2nd edn.), p. 232–4.
  • Bell I, Schwartz G, Amend D, et al. Sensitisatio n to early life stress and response to chemical odors in older adults. Biol Psychiatry 1994; 35: 857–63.
  • Ueda A, Ueda T, Matsushit a T, et al. Prevalenc e rates and risk factors for allergic symptoms among inhabitant s in rural districts. Jpn J Indust Health 1987; 29: 3–16.
  • Anthony HM. Tetracyclin e sensitivit y as a cause of excessiv e flatus. BMJ 1977; 2: 1632.
  • Anthony HM. Chemical sensitivit y due to metabolites. J Nutr Environ Med 1999; 9: 159–163.
  • Klassen CD, Amdur MO, Doull J (eds.) Caserett and Doull’s Toxicology: The Basic Science of Poisons, 1986. New York: Macmillan Publishing.
  • Laseter J, et al Chlorinated hydrocarbo n pesticides in environmentall y sensitiv e patients. Clin Ecol 1983; 2: 3–12.
  • Butcher B, O’Neal CE, Reed MA, et al. Development and loss of toluene diisocyanat e reactivity: immunologic, pharmacologic, and provocativ e challeng e studies. J Allergy Clin Immunol 1982; 70: 231–5.
  • Thrasher JD, Madison R, Broughton A, et al. Building related illness and antibodies to albumin conjugate s of formaldehyde, toluene diisocyanate, and trimetalliti c anhydride. Am J Industria l Med 1989; 15: 187–95.
  • Patterson R, Pateras V, Grammer LC, et al. Human antibodies against formaldehyde –human serum albumin conjugate s or human serum albumin in individual s exposed to formaldehyde. Int Arch Allergy Appl Immunol 1986; 79: 53.
  • Akiyjama K, et al. Hapten–modified basophils: a model of human immediate hypersensitivit y that can be elicited by IgG antibody. J Immunol 1984; 133: 3286–90.
  • Cronin E. Contact Dermatitis. Edinburgh: Churchill Livingstone, 1980.
  • Mavroleo n G, Begishvili B, Frew AJ. Anaphylaxi s to hair dye: a case report. Letter. Clin Exp Allergy 1998; 28(1): 121–2
  • Gracy–Whitman L, Ell S. Artificial colouring s and adverse reactions. BMJ 1995; 310: 1204.
  • Gell PGH, Coombs RRA. Eds. Clinical Aspects of Immunology. Oxford: Blackwells, 1963 p. 317.
  • Miller CS. Toxicant–induced loss of tolerance –an emerging theory of disease? Environ Health Perspect 1997; 105 (Suppl 2): 445–54.
  • Cullen MR (ed.) Workers with Multiple Chemical Sensitivities. Philadelphia: Hanley & Belfus Inc, 1987.
  • Maberly DJ, Anthony HM. Asthma management in a ‘clean’ environment: 1. The effect of challeng e with foods and chemicals on the peak flow rate. J Nutr Med 1992; 3; 215–230.
  • Brodsky CM. Psychologica l factors contributin g to somatofor m disorder s attribute d to the workplace. The case of intoxication. J Occup Med 1983; 25: 459–64.
  • Simon GE, Daniell W, Stockbridge H, et al. Immunologic, psychologica l and neuropsychologica l factors in multiple chemical sensitivity. A controlled study. Ann Intern Med 1993;19:97–103.
  • Black DW, Rathe A, Goldstein RB. Environmental illness: a controlled study of 26 patients with 20th century disease. JAMA 1990; 264: 3166–70.
  • Speckens AEM, van Hemert AM, Spinhoven P, et al. Cognitive behavioura l therapy for medically unexplaine d physical symptoms: a randomised controlle d trial. BMJ 1995; 311: 1328–32.
  • Howard L, Wessely S. Unexplaine d illness. J Roy Soc Med 1996; 89: 180.
  • Creed F, Mayou R, Hopkins A (eds.) Medical Symptoms not Explained by Organic Disease. Royal College of Psychiatrist s & Royal College of Physicians, London, 1992.
  • Dager S, Holland JP, Cowley DS, et al. Panic disorder precipitate d by exposur e to organic solvent s in the workplace. Am J Psychiatry 1987; 144: 1056–8.
  • Goudsmit EM, Gadd R. All in the mind? The psychologisatio n of illness. The Psychologist: Bull Brit Psychologica l Soc 1991; 4: 56–60.
  • Rea WJ, Ross GH, Johnso n AR, et al. Confirmation of chemical sensitivity by means of double blind inhalan t challeng e of toxic volatile chemicals. Clin Ecol 1989; 6: 113–18.
  • Maberly DJ, Anthony HM. Asthma managemen t in a ‘clean’ environment: 2. Progress and outcom e in a cohort of patients. J Nutr Med 1992; 3: 231–48.
  • Maberly DJ, Anthony HM, Birtwistle S. Polysymptomati c patients: a two–centre outcom e audit study. J Nutr Environ Med 1996; 6: 7–32.
  • King DS. Can allergic exposur e provok e psychologica l symptoms? Biological Psychiatr y 1981;16:3–17.
  • Ross GH, Rea WJ, Johnson AR, et al. Neurotoxicit y in single photon emission computed tomography brain scans of patients reporting chemical sensitivities. Toxicol Indust Health 1999; 15: 415–20.
  • Davidoff AL, Fogarty L. Psychogenic origins of multiple chemical sensitivitie s syndrome: a critical review of the researc h literature. Arch Environ Hlth 1994; 49: 316–25.
  • Radcliffe MJ, Ashurst P, Brostof f J. Unexplained illness: the mind versus the environment. J Roy Soc Med 1995; 88: 678–9.
  • Rippere V. Unexplaine d illness. J Roy Soc Med 1996; 89: 419.
  • Jacob KS. The quest for the etiology of mental disorders. J Clin Epidemiol 1994; 47: 97–9.
  • Scheifer SJ, Keller SE, Camerino M, et al. Suppression of lymphocyt e stimulation following bereavement. JAMA 1983; 250: 374–7.
  • Bartrop RW, Lazarus L, Luckhurst E, et al. Depressed lymphocyt e function after bereavement. Lancet 1977; 1: 834–6.
  • Blizard DA, Freedman LS, Liang B. Genetic variation, chronic stress and the central and peripheral noradrenergi c systems. Am J Physiol 1981; 245: R600–5.
  • Laudenslage r ML, Ryan SM, Drugan RC, et al. Coping and immunosuppression: inescapabl e but not escapabl e shock suppresse s lymphocyt e proliferation. Science 1983; 221: 568–70.
  • Ader R, Cohen N. CNS–immune system interactions: conditionin g phenomena. Behav Brain Sci 1985; 8: 379–94.
  • Sorg BA and Prasad BM. Potential role of stress and sensitisatio n in the developmen t and expressio n of multiple chemical sensitivity. Environ Health Perspect 1997; 105 (Suppl 2): 467–71.
  • Egger J, Carter CM, Wilson J, et al. Is migraine food allergy? A double blind controlled trial of oligo–antigeni c diet treatment. Lancet 1983; 2: 865–9.
  • Katsunuma T, Iikura Y, Akasawa A, et al. Wheat–dependen t exercise–induced anaphylaxis: inhibition by sodium bicarbonate. Ann Allergy 1992; 68: 184–8.
  • Rice RL. Symptom patterns of the hyperventilatio n syndrome. Am J Med 1950; 8: 691–700.
  • Moller G (ed.) Neuroimmunology. Imm Rev 1987; 100.
  • Russell M, Dark KA, Cummins RW, et al. Learned histamine release. Science 1984; 224: 733.
  • Bascom R, Meggs WJ, Frampton M, et al. Neurogeni c inflammation: with additiona l discussio n of central and perceptua l integration of nonneurogeni c inflammation. Environ Health Perspect 1997; 105 Suppl 2: 531–7.
  • Bell IR. Neuropsychiatri c aspects of sensitivit y to low–level chemicals: a neural sensitizatio n model. Toxicol Indust Health 1994; 10: 277–312.
  • Antelman SM. Time–dependen t sensitizatio n in animals: a possibl e model of multiple chemical sensitivity. Toxicol Indust Health 1994; 10: 335–42.
  • Gilbert ME. Phenomenolog y of limbic kindling. Toxicol Indust Health 1994; 10: 343–58.
  • Office for National Statistics. Living in Britain. General Househol d Survey for 1996. Stationary Office, 1998.
  • Van Hemert AM, Hengevel d MW, Bolk JH, et al. Psychiatri c disorder s in relation to medical illness among patients of a general medical outpatient clinic. Psychol Med 1993; 23: 167–73.
  • Speckens AEM, van Hemert AM, Spinhoven P, et al. Cognitive behavioura l therapy for medically unexplaine d physical symptoms: a randomised controlle d trial. BMJ 1995; 311: 1328–32.
  • Polosa R. Prevalence of atopy and urban air pollution: dirty business. Clin Exp Allergy 1999; 29: 1439–41.
  • Sibbald B, Rink E, de Souza M. Is the prevalenc e of atopy increasing ? Br J G P 1990; 40: 338–40.
  • Foucard T. Allergy and allergy–like symptoms in 1050 medical students. Allergy 1991; 46: 20–6.
  • Burr ML, Butland BK, King S, et al. Changes in asthma prevalenc e in two surveys 15 years apart. Arch Dis Child 1989; 64: 1452–6.
  • Aberg N. Asthma and allergic rhinitis in Swedish conscripts. Clin Exp Allergy 1989; 19: 59–63.
  • Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304: 87–90.
  • Alun Jones V, Shorthous e M, McLoughlan P, et al. Food intolerance, a major factor in the pathogenesi s of the irritable bowel syndrome. Lancet 1982; 2: 1117–20.
  • Egger J, Carter CM, Wilson J, et al. Is migraine food allergy? A DB controlled trial of oligo–antigeni c diet treatment. Lancet 1983; 2: 865–9.
  • Nsouli TM, Nsouli SM, Linde RE, et al. Role of food allergy in serous otitis media. Ann Allergy 1994; 73: 215–19.
  • Carter CM, Urbanowicz M, Hemsley R, et al. Effects of few food diet in attentio n deficit disorder. Arch Dis Child 1993; 69: 564–8.
  • Steinman HA, Potter PC. The precipitatio n of symptoms by common foods in children with atopic dermatitis. Allergy Proc 1994; 15: 203–10.
  • Bostock J. Case of a periodic affection of the eyes and chest. Medico–Chirurgica l Trans London 1819; x: 161–5.
  • Finn R. John Bostock, hay fever, and the mechanism of allergy. Lancet 1992; 340: 1453–5.
  • Muranaka M, Suzuki S, Kiozumi K, et al. Adjuvant activity of diesel–exhaus t particulate s for the productio n of IgE antibod y in mice. J Allergy Clin Immunol 1986; 77: 616–23.
  • Emberlin J, Savage M, Jones S. Annual variation s in grass pollen seasons in London 1961–1990: trends and forecas t models. Clin Exp Allergy 1993; 23: 911–18.
  • Takafuji S, Suzuki S, Koizumi K, et al. Adjuvant effect of diesel exhaust particulates. J Allergy Clin Immunol 1985; 79: 639–45.
  • Diaz–Sanchez D, Dotson AR, Takenaka H, Saxon A. Diesel exhaust particle s induce local IgE productio n in vivo and alter the patter n of IgE messenge r RNA isoforms. J Clin Invest 1994; 94(4): 1417–25.
  • Hillam RP, Bice DE, Hahn FF, et al. Effects of acute NO2 exposur e on cellular immunity after lung immunisation. Environ Res 1983; 31: 201–11.
  • Dale MM, Foreman JC. Textbook of Immunopharmocology. Oxford: Blackwells, 1989, p. 192.
  • Diaz–Sanchez D, Tsien A, Fleming J, Saxon A. Combined diesel exhaust particulat e and ragweed allerge n challeng e markedly enhance s human in vivo nasal ragweed–specific IgE and skews cytokin e productio n to a T helper cell 2–type pattern. J Immunol 1997; 158(5): 2406–13.
  • van Steenis D, personal communication.
  • Van Niekerk CH, Weinberg EG, Shore SC, et al. Prevalence of asthma: a comparative study of urban and rural Xhosa children. Clin Allergy 1979; 9: 319–24.
  • Mocarelli P, Brambilla P, Gerthoux P, et al. Change in sex ratio with exposur e to dioxin. Lancet 1996; 348: 409.
  • Williams R. Biochemical Individuality. Austin and London: Texas Press, 1977.
  • Miller C, Ashford N, Doty R, et al. Working Group Report. Empirical approache s for the investigatio n of toxicant –induced lack of tolerance. Environmenta l Health Perspectives 1997; 105, Suppl 2: 515–20.
  • McLaren–Howard J. Biolab Medical Unit, 9 Weymouth Street, London W1N 3FF.
  • Wraith DG. Asthma and rhinitis. Clin Immunol Allergy 1982; 2: 101–12.
  • LeRoy J, Davis T, Jason L. Treatment efficacy: A survey of 305 MCS patients. CFIDS Chronicle 1996;Winter: 52–3.
  • Barron SR. Survey of the Medical Impact on Environmentall y Hypersensitiv e People of a Change in Habitat. Monograph published by Canada Mortgage and Housing Corporation, 30 April 1990.
  • Drerup O, Matlock C, Rousseau D, Salaris V. Housing for the Environmentall y Hypersensitiv e (Survey and examples of clean air housing in Canada). Monograp h published by Canada Mortgage and Housing Corporation, July 1990.
  • Anderson JH. Reactions to Carpet Emissions: A Case Series. J Nutr Env Med 1997; 7: 177–85.
  • Anderson KE. Dietary regulation of cytochrom e P450. Ann Rev Nutr 1991; 11: 141–67.
  • Guengeric h FP. Effects of nutritive factors on metabolic processes involving bioactivatio n and detoxicatio n of chemicals. Ann Rev Nutr 1984; 4: 207–31.
  • McFadden SA Phenotypi c variatio n in xenobioti c metabolism and adverse environmenta l response: focus on sulfur–dependen t detoxification pathways. Toxicolog y 1996; 111(1–3): 43–65.
  • Eaton KK, Hunnisett A. Abnormalities in essential amino acids in patients with chronic fatigue syndrome. J Nutr Med 1991; 2: 369–75.
  • Ross GH, Rea WJ, Johnson AR, et al. Evidence for vitamin deficiencies in environmentally –sensitive patients. Clin Ecol 1989; 6: 60–6.
  • Bland JS, Bralley JA. Nutritiona l upregulatio n of hepatic detoxicatio n enzymes. J App Nutr 1992; 44(3&4): 2–15.
  • Lonsdale D. Gilbert’s disease: symptomatic response to nutritiona l supplementatio n in ten patients. J Nutr Med 1992; 3: 319–24.
  • Rea WJ. Chemical Sensitivity: Vol 4. Boca Raton, USA: Lewis Publishers, 1997.
  • Buist RA. Chronic fatigue syndrome and chemical overload. Int Clin Nutr Rev 1988; 4: 173–5.
  • [241] Schnare DW, Ben M, Shields MG. Body burden of PCBs, PBBs and chlorinate d pesticide s in human subjects. Ambio 1984; 13: 378–80.
  • Root DE, Lionelli GT. Excretion of a lipophili c toxican t through the sebaceou s glands: a case report. J Toxicol Cut Ocul Toxicol 1987; 6: 13–17.
  • Tretjak Z, Shields M, Beckmann SL. PCB reductio n and clinical improvemen t by detoxification: an unexploite d approach ? Hum Exp Toxicol 1990; 9(4): 235–44.
  • Rea WJ, Pan Y, Johnso n AR, et al. Reduction of Chemical Sensitivit y by Means of Heat Depuration, Physical Therapy and Nutritional Supplementatio n in a Controlle d Environment. J Nutr Env Med 1996; 6: 141–8.
  • Kontoghiorghe s GJ. New concept s of iron and aluminium chelatio n therapy with oral L1 (deferiprone) and other chelators. A review. Analyst 1995; 120: 845–51.
  • Sandborgh Englund G, Dahlqvist R, Lindelof B, et al. DMSA administratio n to patients with alleged mercury poisonin g from dental amalgams: a placebo –controlled study. J Dent Res 1994; 73: 620–8.
  • Grandjean P, Guldager B, Larsen IB, et al. Placebo response in environmenta l disease. Chelation therapy of patients with symptoms attributed to amalgam fillings. J Occup Environ Med 1997; 39: 707–14.
  • Yokel RA, Ackrill P, Burgess E, et al. Prevention and treatment of aluminium toxicity includin g chelation therapy: status and research needs. J Toxicol Environ Health 1996; 48: 667–83.
  • Lin JL, Ho HH, Yu CC. Chelation therapy with elevated body lead burden and progressiv e renal insuf ficiency. A randomised controlle d trial. Ann Inter n Med 1999; 130: 7–13.
  • Lin JL, Lim PS. Disappearanc e of immune deposit s with EDTA chelatio n therapy in a case of IgA nephropathy. Am J Nephrol 1992; 12: 457–60.
  • Elihu N, Anandasbapath y S, Frishman WH. Chelation therapy in cardiovascula r disease: ethylenedi - aminetetraaceti c acid, deferoxamine, and dexrazoxane. J Clin Pharmocol 1998; 38: 101–5.
  • Olszewer E, Carter JP. EDTA chelation therapy in chronic degenerativ e disease. Med Hypotheses 1988; 27: 41–9.
  • Davies S, McLaren Howard J, Hunnisett AG, et al. Age–related increas e in toxic metal levels in hair, sweat and whole blood in 37,081 patients. 1999 (Submitted for publication).
  • Miller JB. Techniques of immunotherapy. J Nutr Med 1992; 3: 211–14.
  • McEwen LM. Hyposensitisation. In: Brostoff J, Challacombe SJ (eds.) Food Allergy and Intolerance .London: Bailliere Tindall, 1987; 985–94.
  • Anthony H, Birtwistle S, Eaton K, Maberly J. Environmental Medicine in Clinical Practice. BSAENM Publications, Southampton, 1997, p. 22–3.
  • Radcliffe MJ, Lampe FC, Brostoff J. Allergen specific low dose immunotherapy in perennia l allergicrhinitis; a double–blind placebo –controlled cross–over study. J Invest Allergol Clin Immunol 1996; 6: 242–7.
  • Fell P, Brostoff J. A single dose desensitizatio n for summer hay fever. Results of a double blind study–1988. Europ J Clin Pharmacol 1990; 38: 77–9.
  • King WP, Fadal RG, Ward WA, et al. Provocation /neutralisation: a two–part study. Part II. Subcuta- neous neutralizatio n therapy: a multi–center study. Otolaryngo l Head Neck Surg 1988; 99: 272–7.
  • Egger J, Stolla A. Controlled trial of hyposensitisatio n in children with food–induced hyperkineti c syndrome. Lancet 1992; 339: 1150–3.
  • Rippere V. The mental state of dismissed patients –an enquiry into dismissal injury. 4. Dismissal injury as a form of post traumatic stress disorder. Newsletter of the Soc for Environmenta l Ther 1992; 12: 61–71.
  • Randolph TG. Environmental Medicine –Beginning s and Biographie s of Clinical Ecology. Colorado, Clinical Ecology Publ Inc, 1987.
  • Rea WJ. Environmentally –triggere d cardiac disease. Ann Allergy 1978; 40: 243–51.
  • Rea WJ, Peters DW, Smiley RE, et al. Recurrent environmentally –triggere d thrombo–phebitis: a five year follow–up. Ann Allergy 1981; 47: 338–44.
  • Rea WJ. Environmentally –triggere d small vessel vasculitis. Ann Allergy 1977; 38: 245–51.
  • Maberly DJ, Anthony HM. A reversibl e back pain syndrome: report of two cases. J Nutr Med 1991; 2; 83–7.
  • Anthony HM, Maberly DJ. Weight changes in chronicall y ill patients with evidence of multiple intoleranc e to foods, chemicals and inhalants. J Nutr Med 1991; 2: 131–41.
  • Anthony HM, Maberly DJ. Time of onset of symptoms after food challenge. J Nutr Med 1991; 2: 121–30.
  • Anthony H, Birtwistle S, Eaton K, Maberly J. Environmental Medicine in Clinical Practice. BSAENM Publications, Southampton, 1997, p. 231.
  • Ashford NA, Miller CS. Chemical Sensitivity: A repor t to the New Jersey Department of Health, December 1989.
  • Ashford NA, Miller CS. Chemical Exposures: Low Levels and High Stakes. Lewis, Boca Raton, 1994.
  • AAAAI Board of Directors. Position statement. J Allergy Clin Immunol 1999; 103: 36–40.
  • Hirsh SR, Kalbfleich JH. Circulating basophil s in normal individual s and subject s with hay fever. J Allergy Clin Immunol 1976; 58: 676.
  • Anthony HM, Birtwistle S, Brostoff J, et al. Letter. Food intolerance. Lancet 1994; 344: 136–7.
  • Evaluation of Satisfactio n at the Nova Scotia Environmenta l Medicine Clinic, Halifax, Canada.Monograp h publishe d by the Nova Scotia Department of Health, 1993.
  • Czeizel A, Dudas I, et al. The effect of periconceptua l multivitamin–mineral supplementatio n on vertigo, nausea, & vomiting in the 1st trimester of pregnancy. Arch Gynecol Obstet 1992; 251: 181–5.
  • Czeizel AE, Dudas I, Metneki J. Pregnancy outcomes in a randomised controlled trial of periconcep - tual multivitamin supplementation. Arch Gynaecol Obstet 1994; 255: 131–9.
  • Ward N. Preconceptua l care and pregnancy outcome. J Nutr Med 1995; 5: 205.
  • EEA and UNEP. Chemicals in the European Environment: Low Doses, High Stakes? Geneva and Copenhagen: EEA, 1998. Kongens Nytorv 6, DK-1050 Copenhagen K.
  • DETR Sustainabl e Production and Use of Chemicals. Department of Environment Transpor t and the Regions. HMSO: London, 1998.
  • Ibarra J. How to detect head lice: the changing emphasis in health education. Health at School 1988; 3: 109–12.
  • Role of the Primary Care Physician in Occupationa l and Environmental Medicine. Division of Health Promotion and Disease Prevention, Institut e of Medicine, National Academy of Sciences. National Academy Press, Washington DC, 1988.
  • Maberly DJ, Anthony HM. Multiple Chemical Sensitivity: phased initiatio n by anaesthetic s and a new building. J Nutr Environ Med (submitted for publicatio n 2000).
  • Alanko K, Keskinen H, Bjorksten F, et al. Immediate–type hypersensitivit y to reactive dyes. Clin Allergy 1978; 8: 25–31.
  • Yoshida S, Makami H, Nakagawa H, et al. Amalgam allergy associate d with exacerbatio n of aspirin–intolerant asthma. Clin Exp Allergy 1999; 29: 1412–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.